For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Shaman Pharmaceuticals, Inc.

USPTO Granted Patents = 22

Forward Citations = 169

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Donald E Bierer (14 out of 14 patents)

Jian Luo (6 out of 32 patents)

Jeffrey M Dener (6 out of 8 patents)

4. Michael S Tempesta (5 out of 5 patents)

5. Thien V Truong (4 out of 4 patents)

6. Diana M Fort (4 out of 4 patents)

7. Wayne D Inman (3 out of 3 patents)

8. Reimar C Bruening (3 out of 3 patents)

9. Steven Row King (3 out of 5 patents)

10. Masato Koreeda (2 out of 11 patents)

11. Bernard Loev (2 out of 44 patents)

12. Wu Yang (2 out of 3 patents)

13. Richard Hector (2 out of 2 patents)

14. Joseph L Evans (2 out of 2 patents)

15. Larisa G Dubenko (2 out of 2 patents)

22 patents: Sort by Forward Citations

1. 5925647 - Methods for use of cryptolepine analogs with hypoglycemic activity (1999-07-20),

2. 5917052 - Hypoglycemic agent from cryptolepis (1999-06-29),

3. 5837255 - Method of reducing blood glucose by administering Harunganin or Vismin (1998-11-17),

4. 5827898 - Use of bisphenolic compounds to treat type II diabetes (1998-10-27),

5. 5811568 - Process for the preparation of mono- and bis(phosphocholine) (1998-09-22),

6. 5753790 - Hypoglycemic agent from cryptolepis (1998-05-19),

7. 5747527 - Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of (1998-05-05),

8. 5741926 - Aniline derivatives having antihyperglycemic activity (1998-04-21),

9. 5691386 - Triterpenoid compound for the treatment of diabetes (1997-11-25),

10. 5681958 - Cryptolepine analogs with hypoglycemic activity (1997-10-28),

11. 5681829 - Class of phosphocholine derivatives having antifungal activity (1997-10-28),

12. 5674900 - Terpenoid-type quinones for treatment of diabetes (1997-10-07),

13. 5668168 - 1,2-dithiin antiinfective agents (1997-09-16),

14. 5648354 - 1,2-dithiins having antifungal activity (1997-07-15),

15. 5629319 - Hypoglycemic agent from cryptolepis (1997-05-13),

Company Overview

Shaman Pharmaceuticals, Inc. is a biotechnology company based in South San Francisco, California, focused on the discovery and development of novel therapeutic agents derived from traditional medicinal plants. The company specializes in ethnobotanical research, leveraging indigenous knowledge to identify potential pharmaceutical compounds. Shaman Pharmaceuticals aims to address unmet medical needs through innovative drug development, emphasizing the importance of biodiversity and sustainable practices in its research efforts.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

22 Patents

#58 in South San Francisco, CA

#3,582 in California

#15,021 in US

#28,749 in the World

South San Francisco, CA, United States of America

Shaman Pharmaceuticals, Inc.

Forward Citations = 169

28 inventors:

Donald E Bierer (14 out of 14 patents)

Jian Luo (6 out of 32 patents)

Jeffrey M Dener (6 out of 8 patents)

4. Michael S Tempesta (5 out of 5 patents)

5. Thien V Truong (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Shaman Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/shaman-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…